✦ LIBER ✦

Biological markers as indicators of response to primary and adjuvant chemotherapy in breast cancer

✍ Scribed by Maria Grazia Daidone; Silvia Veneroni; Elvira Benini; Gorana Tomasic; Danila Coradini; Marinella Mastore; Cristina Brambilla; Laura Ferrari; Rosella Silvestrini

Publisher: John Wiley and Sons
Year: 1999
Tongue: French
Weight: 126 KB
Volume: 84
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19991222)84:6<580::aid-ijc7>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biological markers as indicators of path

Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers

✍ Aurora Costa; Lisa Licitra; Silvia Veneroni; Maria G. Daidone; Cesare Grandi; Ra 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 73 KB 👁 2 views

Impaired primary, but not secondary, imm

Impaired primary, but not secondary, immune response in breast cancer patients under adjuvant chemotherapy

✍ Christoph C. Zielinski; Ingrid Stuller; Friedrich Dorner; Paul Pötzi; Christian 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB 👁 1 views

Systemic chemotherapy as an adjuvant to

Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancer

✍ Bernard Fisher 📂 Article 📅 1969 🏛 John Wiley and Sons 🌐 English ⚖ 334 KB 👁 2 views

Peripheral lymphocyte and eosinophil cou

Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer

✍ Helen E. Ownby; Larry D. Roi; Ruth R. Isenberg; Michael J. Brennan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB 👁 1 views

Responses to chemotherapy or chemohormon

Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081

✍ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB 👁 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3

Response to secondary therapy in patient

Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy

✍ J. D. Bitran; R. K. Desser; C. M. Shapiro; A. Michel; M. F. Kozloff; A. A. Billi 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 2 views